Search Results : Cancer

1954 interactions found:

Novel Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
X-ray repair cross complementing 6
Name2
succinate dehydrogenase complex subunit C
Pathway 1
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation
Pathway 2
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
  • Maturation of TCA enzymes and regulation of TCA cycle
Drugs 1
Drugs 2
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • Ubiquinone Q1
Diseases 1
Diseases 2
Novel
Novel
Name 1
X-ray repair cross complementing 6
Name2
ring finger protein 146
Pathway 1
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation
Pathway 2
  • TCF dependent signaling in response to WNT
  • Degradation of AXIN
  • Ub-specific processing proteases
  • Regulation of PTEN stability and activity
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
X-ray repair cross complementing 6
Name2
granzyme B
Pathway 1
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation
Pathway 2
  • NOTCH2 intracellular domain regulates transcription
  • Pyroptosis
  • Activation, myristolyation of BID and translocation to mitochondria
  • Nuclear events stimulated by ALK signaling in cancer
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
X-ray repair cross complementing 6
Name2
zinc finger protein 512B
Pathway 1
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation
Pathway 2
  • RHOV GTPase cycle
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
melanocyte inducing transcription factor
Name2
transcription factor EB
Pathway 1
  • SUMOylation of transcription factors
  • Transcriptional and post-translational regulation of MITF-M expression and activity
Pathway 2
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes
Drugs 1
Drugs 2
Diseases 1
  • Malignant melanoma
  • Ocular albinism; Ocular albinism, type I (OA1); Waardenburg syndrome, type II (WS2-OA)
  • Waardenburg syndrome (WS)
Diseases 2
Novel
Novel
Symbols
Name 1
Y-box binding protein 1
Name2
junctional adhesion molecule 2
Pathway 1
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
  • Interferon gamma signaling
  • Noncanonical activation of NOTCH3
Pathway 2
  • Cell surface interactions at the vascular wall
  • Integrin cell surface interactions
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
melanocortin 4 receptor
Name2
attractin like 1
Pathway 1
  • Peptide ligand-binding receptors
  • G alpha (s) signalling events
  • Transcriptional and post-translational regulation of MITF-M expression and activity
Pathway 2
Drugs 1
  • Bremelanotide
  • Setmelanotide
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
minichromosome maintenance complex component 7
Name2
MAP3K12 binding inhibitory protein 1
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
  • HATs acetylate histones
  • Formation of WDR5-containing histone-modifying complexes
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
minichromosome maintenance complex component 7
Name2
minichromosome maintenance 8 homologous recombination repair factor
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
  • E2F-enabled inhibition of pre-replication complex formation
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • CDC6 association with the ORC:origin complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
minichromosome maintenance complex component 7
Name2
chromosome 8 open reading frame 34
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
minichromosome maintenance complex component 7
Name2
centrosomal protein 68
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
minichromosome maintenance complex component 7
Name2
ring finger protein 181
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
  • E3 ubiquitin ligases ubiquitinate target proteins
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
insulin like growth factor binding protein 5
Pathway 1
  • PPARA activates gene expression
Pathway 2
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
four and a half LIM domains 2
Name2
KIAA1217
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
glyoxylate reductase 1 homolog
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
BARX homeobox 2
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
TOX high mobility group box family member 3
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
APOBEC1 complementation factor
Pathway 1
  • PPARA activates gene expression
Pathway 2
  • mRNA Editing: C to U Conversion
  • Formation of the Editosome
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
PBX/knotted 1 homeobox 2
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
interleukin 16
Pathway 1
  • PPARA activates gene expression
Pathway 2
  • Other interleukin signaling
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
X-ray repair cross complementing 6
Name2
succinate dehydrogenase complex subunit C
Pathway 1
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation
Pathway 2
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
  • Maturation of TCA enzymes and regulation of TCA cycle
Drugs 1
Drugs 2
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • Ubiquinone Q1
Diseases 1
Diseases 2
Novel
Name 1
X-ray repair cross complementing 6
Name2
ring finger protein 146
Pathway 1
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation
Pathway 2
  • TCF dependent signaling in response to WNT
  • Degradation of AXIN
  • Ub-specific processing proteases
  • Regulation of PTEN stability and activity
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
X-ray repair cross complementing 6
Name2
granzyme B
Pathway 1
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation
Pathway 2
  • NOTCH2 intracellular domain regulates transcription
  • Pyroptosis
  • Activation, myristolyation of BID and translocation to mitochondria
  • Nuclear events stimulated by ALK signaling in cancer
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
X-ray repair cross complementing 6
Name2
zinc finger protein 512B
Pathway 1
  • 2-LTR circle formation
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • Neutrophil degranulation
Pathway 2
  • RHOV GTPase cycle
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
melanocyte inducing transcription factor
Name2
transcription factor EB
Pathway 1
  • SUMOylation of transcription factors
  • Transcriptional and post-translational regulation of MITF-M expression and activity
Pathway 2
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes
Drugs 1
Drugs 2
Diseases 1
  • Malignant melanoma
  • Ocular albinism; Ocular albinism, type I (OA1); Waardenburg syndrome, type II (WS2-OA)
  • Waardenburg syndrome (WS)
Diseases 2
Novel
Symbols
Name 1
Y-box binding protein 1
Name2
junctional adhesion molecule 2
Pathway 1
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
  • Interferon gamma signaling
  • Noncanonical activation of NOTCH3
Pathway 2
  • Cell surface interactions at the vascular wall
  • Integrin cell surface interactions
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
melanocortin 4 receptor
Name2
attractin like 1
Pathway 1
  • Peptide ligand-binding receptors
  • G alpha (s) signalling events
  • Transcriptional and post-translational regulation of MITF-M expression and activity
Pathway 2
Drugs 1
  • Bremelanotide
  • Setmelanotide
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
minichromosome maintenance complex component 7
Name2
MAP3K12 binding inhibitory protein 1
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
  • HATs acetylate histones
  • Formation of WDR5-containing histone-modifying complexes
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
minichromosome maintenance complex component 7
Name2
minichromosome maintenance 8 homologous recombination repair factor
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
  • E2F-enabled inhibition of pre-replication complex formation
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • CDC6 association with the ORC:origin complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
minichromosome maintenance complex component 7
Name2
chromosome 8 open reading frame 34
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
minichromosome maintenance complex component 7
Name2
centrosomal protein 68
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
minichromosome maintenance complex component 7
Name2
ring finger protein 181
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
  • E3 ubiquitin ligases ubiquitinate target proteins
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
insulin like growth factor binding protein 5
Pathway 1
  • PPARA activates gene expression
Pathway 2
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
four and a half LIM domains 2
Name2
KIAA1217
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
glyoxylate reductase 1 homolog
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
BARX homeobox 2
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
TOX high mobility group box family member 3
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
APOBEC1 complementation factor
Pathway 1
  • PPARA activates gene expression
Pathway 2
  • mRNA Editing: C to U Conversion
  • Formation of the Editosome
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
PBX/knotted 1 homeobox 2
Pathway 1
  • PPARA activates gene expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
four and a half LIM domains 2
Name2
interleukin 16
Pathway 1
  • PPARA activates gene expression
Pathway 2
  • Other interleukin signaling
Drugs 1
Drugs 2
Diseases 1
Diseases 2

Page 39 out of 98 pages

© Madhavi K. Ganapathiraju 2012-2025